首頁 › 急性淋巴母細胞性白血病 › 馬里蘭 › Baltimore
Baltimore, MD 的 急性淋巴母細胞性白血病 臨床試驗
9 項針對 急性淋巴母細胞性白血病 的研究正在 Baltimore（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
招募中觀察性研究歡迎健康志工
- Mercy Medical Center, Baltimore
- Sinai Hospital of Baltimore, Baltimore
- MedStar Franklin Square Medical Center/Weinberg Cancer Institute, Baltimore
- 還有 2 項
Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
招募中早期第 1 期
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
招募中1/2 期
- Sinai Hospital of Baltimore, Baltimore
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
Multicenter HomeVENT: Home Values and Experiences Navigation Track
招募中歡迎健康志工
- Johns Hopkins University School of Medicine, Baltimore
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
招募中觀察性研究
- Johns Hopkins, Baltimore
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
招募中觀察性研究
- Sinai Hospital of Baltimore, Baltimore
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
招募中1/2 期
- Sibley Memorial Hospital, Baltimore
- University of Maryland, Baltimore
- Johns Hopkins Main Center, Baltimore
Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL
招募中1 期
- University of Maryland, Baltimore
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
招募中1 期
- Johns Hopkins University, Baltimore
其他城市的 急性淋巴母細胞性白血病 試驗
- Houston, TX28 項研究
- New York City, NY24 項研究
- Baldwin Park, CA21 項研究
- Seattle, WA21 項研究
- Chicago, IL19 項研究
- Atlanta, GA19 項研究
- Memphis, TN16 項研究
- Philadelphia, PA16 項研究
- Washington, DC16 項研究
- Boston, MA15 項研究
- Los Angeles, CA14 項研究
- Durham, NC13 項研究
Baltimore 的其他研究
- 非小細胞肺癌60 項研究
- 乳癌47 項研究
- 前列腺癌43 項研究
- 肺癌40 項研究
- 癌症（所有類型）37 項研究
- 大腸直腸癌31 項研究
- 胰臟癌31 項研究
- 轉移性癌症28 項研究
- 肥胖症25 項研究
- 心臟衰竭24 項研究
- 膀胱癌24 項研究
- 中風22 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月5日。各研究自行設定資格標準；由研究團隊決定參與者資格。